Coromandel International Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
COROMANDEL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.5 pts more than Nifty Midcap 150 and 4.2 pts more than its Fertilizers peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Coromandel International reported strong Q1 FY26 results with standalone revenue from operations of Rs. 7,001.32 crores, up about 48.5% year-on-year from Rs. 4,713.30 crores. Standalone net profit jumped roughly 53.6% to Rs. 508.23 crores from Rs. 330.96 crores, while consolidated revenue rose to Rs. 7,042.30 crores and consolidated net profit climbed to Rs. 501.59 crores. The statutory auditor S.R. Batliboi & Associates LLP issued an unmodified (clean) review report on both standalone and consolidated results. The board also approved acquiring an additional 17.69% stake in Senegal-based Baobab Mining and Chemicals Corporation (BMCC) for USD 7.70 million through wholly owned subsidiary Coromandel Chemicals Limited, raising the stake from 53.82% to 71.51% to secure long-term rock phosphate supply. Additionally, the board approved Rs. 137 crore capital expenditure for a new bagging plant at Kakinada as part of granulation capacity expansion, and noted the resignation of the Head of Legal effective July 28, 2025.
Robust double-digit revenue and profit growth reflect strong operating momentum in both the Nutrient and Crop Protection segments, which is positive for earnings sentiment. The deeper BMCC holding strengthens backward integration into a key raw material, while the Kakinada capex should support future granulation volumes and cost efficiency, both constructive for long-term shareholder value.